BridgeBio Pharma, Inc. Business Finance Contracts & Agreements

36 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture for 1.75% Convertible Senior Notes due 2031 between BridgeBio Pharma, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2025
Underwriting Agreement between BridgeBio Pharma, Inc. and Underwriters (J.P. Morgan, Cantor Fitzgerald, Mizuho) dated March 5, 2024
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2024
Amendment Letter Agreement to License Agreement between Novartis International Pharmaceutical Ltd. and QED Therapeutics, Inc. (May 4, 2018)
Modification Agreements
BridgeBio Pharma, Inc.
Biotechnology
MA
2024
Registration Rights Agreement between BridgeBio Pharma, Inc. and Purchasers (September 25, 2023)
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Securities Purchase Agreement between BridgeBio Pharma, Inc. and Purchasers (September 25, 2023)
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2023
Non-Qualified Stock Option Agreement for Directors under the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan
Warrant Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Non-Qualified Stock Option Agreement under the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan
Warrant Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
BridgeBio Pharma, Inc. Restricted Stock Award Agreement under 2021 Amended and Restated Stock Option and Incentive Plan
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
BridgeBio Pharma, Inc. 2021 Restricted Stock Unit Award Agreement
Equity Distribution Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Non-Qualified Stock Option Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan
Warrant Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
BridgeBio Pharma, Inc. Restricted Stock Award Agreement under Amended and Restated 2019 Inducement Equity Plan
Equity Distribution Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
BridgeBio Pharma, Inc. Common Stock Underwriting Agreement with Goldman Sachs, Evercore, and Morgan Stanley (March 2023)
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Loan and Security Agreement between BridgeBio Pharma, Inc. and U.S. Bank National Association (as Agent)
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2022
Description of Capital Stock and Registration Rights Agreement of BridgeBio Pharma, Inc.
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2022
Sixth Amendment to Loan and Security Agreement among BridgeBio Pharma, Inc., Affiliates, and Hercules Capital, Inc.
Modification Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Fifth Amendment to Loan and Security Agreement among BridgeBio Pharma, Inc., Affiliates, and Hercules Capital, Inc.
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Third Amendment to Loan and Security Agreement among BridgeBio Pharma, Inc., BridgeBio Pharma LLC, BridgeBio Services Inc., Sub20, Inc., and Hercules Capital, Inc.
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Description of Capital Stock and Registration Rights Agreement of BridgeBio Pharma, Inc.
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
BridgeBio Pharma, Inc. Common Stock Underwriting Agreement with Goldman Sachs & Co. LLC, February 2021
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2021
Call Option Transaction Confirmation between BridgeBio Pharma, Inc. and Dealer (ISDA Master Agreement)
Financing Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
Indenture for 2.25% Convertible Senior Notes due 2029 between BridgeBio Pharma, Inc. and U.S. Bank National Association
Indenture Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
BridgeBio Pharma, Inc. $650,000,000 2.25% Convertible Senior Notes Due 2029 Purchase Agreement with Initial Purchasers
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2021
Indenture for 2.50% Convertible Senior Notes due 2027 between BridgeBio Pharma, Inc. and U.S. Bank National Association
Indenture Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2020
BridgeBio Pharma, Inc. $475,000,000 2.500% Convertible Senior Notes Due 2027 Purchase Agreement with Initial Purchasers
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2020
Description of BridgeBio Pharma, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2020
Loan and Security Agreement among Silicon Valley Bank, Hercules Capital, Inc., and Eidos Therapeutics, Inc. dated November 13, 2019
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
BridgeBio Pharma, Inc. Registration Rights Agreement with KKR and Viking (June 26, 2019)
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
BridgeBio Pharma, Inc. Registration Rights Agreement with KKR and Viking (2019)
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Common Stock Certificate for BridgeBio Pharma, Inc.
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
BridgeBio Pharma, Inc. and BridgeBio Pharma LLC Common Stock Underwriting Agreement with J.P. Morgan, Goldman Sachs, Jefferies, and SVB Leerink (2019)
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
Second Amendment to Loan and Security Agreement among BridgeBio Pharma LLC, BridgeBio Services Inc., Sub20, Inc., and Hercules Capital, Inc.
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Asset Purchase Agreement among Phoenix Tissue Repair, Inc., Shire Human Genetic Therapies, Inc., and Lotus Tissue Repair, Inc. dated July 21, 2017
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2019
Asset Purchase Agreement between Alexion Pharma Holding Unlimited Company, Origin Biosciences, Inc., and BridgeBio Pharma, LLC (June 7, 2018)
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
First Amendment to Loan and Security Agreement among BridgeBio Pharma LLC, BridgeBio Services Inc., Sub20, Inc., and Hercules Capital, Inc.
Modification Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Loan and Security Agreement among BridgeBio Pharma LLC, BridgeBio Services Inc., and Hercules Capital, Inc. (June 19, 2018)
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Registration Rights Agreement among [Company], KKR, Viking, and Other Holders of Registrable Securities
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019